Bayer Pharma continues to boost its presence in the Asia-Pacific
2015 regional revenue rises 7% to 4b euros; clinical trials triple in 9 years
Nisha Ramchandani
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
The number of clinical trials conducted by Bayer Pharmaceuticals in Asia Pacific has more than tripled since 2007 - from 21 to 68 - as the healthcare group strengthens its focus on the region.
Here in Singapore, the number of trials has expanded nearly fourfold to 22 from six in the same time frame.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
South-east Asian markets account for 8.8% of global capital inflows from 2021 to 2024: report